Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-20
2009-08-18
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S515000
Reexamination Certificate
active
07576120
ABSTRACT:
A compound selected from those of formula (I):whereinm and n, which may be identical or different, each represent an integer from 0 to 2 inclusive, with the sum of the two integers being from 2 to 3 inclusive,p and q, which may be identical or different, each represent an integer from 0 to 2 inclusive,Alk represents an alkylene, alkenylene or alkynylene chain,X represents an oxygen atom, a sulphur atom or an —N(R)— group wherein R represents a hydrogen atom or an alkyl group,Y, Y′ and W are as defined in the description, its enantiomers, diastereoisomers, and addition salts thereof with one or more pharmaceutically acceptable acid or base.Medicinal products containing the same which are useful for treating conditions associated with central histaminergic systems.
REFERENCES:
patent: 5703091 (1997-12-01), Munschauer et al.
patent: 7034182 (2006-04-01), Fang et al.
patent: 02/06223 (2002-01-01), None
Svendsen et al., 1988, CAS: 109:210691.
International Preliminary Report on Patentability for PCT/FR2005/000382 of Nov. 1, 2006.
Faghih, et al., “Aminoalkoxybiphenylnitriles as Histamine-3 Receptor Ligands” Bioorganic and Medicinal Chemistry Letters, vol. 112, pp. 3077-3079, 2002.
International Search Report for PCT/FR2005/000382 of Jul. 7, 2005.
Witkin, et al.,Pharmacology and Therapeutics, 2004, 103, 1-20.
Leurs, et al.,TiPS, 1998, vol. 19, 177-183.
Arrang, et al.,Nature, 1983, 302, 832-837.
Leurs, et al.,Nature Reviews/Drug Discovery, 2005, vol. 4, 107-120.
Passani, et al.,European Journal of Neuroscience, 2001, 14, 1522-1532.
Prast, et al.,Brain Research, 1996, 734, 316-318.
Ligneau, et al.,J. Pharm. Exper. Ther., 1998, 287, 658-666.
Fox, et al.,Behav. Brain Res., 2002, 131, 151-161.
Fox, et al.,J. Pharm. Exper. Ther., 2003, 305, 897-908.
Meguro, et al.,Pharmacology Biochemistry and Behavior, 1995, 50, 321-325.
Giovannini, et al.,Behav. Brain Res., 1999, 104, 147-155.
Stark, et al.,Arch. Pharm. Pharm. Med. Chem., 1998, 331, 211-218.
Onodera, et al.,Naunyn-Schmiedeberg's Arch Pharmacol, 1998, 357, 508-513.
Bacciottini, et al.,Behav. Brain Res., 2001, 124, 183-194.
Bert Lionel
Casara Patrick
Chollet Anne-Marie
Dhainaut Alain
Lestage Pierre
Hueschen and Sage
Les Laboratoires Servier
Shiao Rei-tsang
LandOfFree
Azabicyclic compounds, a process for their preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabicyclic compounds, a process for their preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclic compounds, a process for their preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4054715